COMPOUNDING
This preparation is used as an antiemetic.
Since there is currently a shortage, this product may be compounded to meet patients’ needs.
This drug is approved with restricted distribution for certain cases of erythema nodosum leprosum and multiple myeloma.
This topical preparation may be used to treat Raynaud’s phenomenon and progressive diabetic foot ulcers.
This semisynthetic aminoglycoside antibiotic is presently in short supply.
Product shortages and lack of availability may render it necessary for the pharmacist to compound a suitable alternative.
This formulation can be compounded for use until the manufactured product—recently in short supply—is readily available.
This compound contains six active ingredients with varying mechanisms of pain relief.
This preparation combines an emollient component, which is beneficial for cracked skin, with bacterial action.
Patients with orofacial neuropathic pain can benefit from this preparation.
This formulation should be prepared according to strict aseptic
technique by a pharmacist validated in aseptic compounding methods.
Tea tree oil, which is used to treat some skin disorders, has fungicidal and bactericidal properties.
Patients taking cholesterol-lowering drugs may use this preparation supplementally.
This form may be used by patients unable to take the oral solid form of this anticonvulsant.
This topical agent may be used for such infections as tinea pedis, tinea cruris, and tinea corporis.
This product warms up as it is smoothed into the skin, which may render it more viscous and rub-resistant.
This formulation is an alternative for patients who are unable to swallow the tablets.
This formulation provides relief for sore muscles and mild-to-moderate joint pain.
This updated compound is more uniform and reliable than the alkaline bladder formulation on which it is based.
Patients with mild-to-moderate neuropathic pain can benefit from treatment with this product.
When a product is discontinued for economic reasons and is no longer available, it still may be prescribed through compounding.
This dosage form, especially suitable for children, allows for easier administration and flexibility in dosing.
Menopausal symptoms and some female hormonal disorders can benefit from treatment with this preparation.
This chemotherapeutic agent is formulated without Aromatic Elixir USP,
which is not available commercially and is time-consuming to prepare.
This simple, easily modifiable preparation is useful for treating skin
dryness or irritation brought on by low-humidity indoor settings.
Some corticosteroid-responsive skin disorders may be treated with this topical preparation.
A liquid version of this influenza medication may be easily prepared using the capsule formulation.
In lozenge form, this analgesic and anesthetic agent can be prepared to suit the patient's individual flavor preference.
Pain and inflammatory conditions of the oral cavity may be relieved with this preparation.
The key ingredient in this compound is used for the alleviation of minor skin irritations and disorders.
Swimmer's ear, a common summertime ailment, may be treated with this antibiotic preparation.
Treatment with this preparation may minimize the progression of skin
damage from actinic keratoses and help prevent skin cancers from
developing.
The FDA's position seems to cast aspersions on the entire compounding community.
This preparation can be applied to the surface of open ulcers and wounds.
This high-risk compound, which is used to relieve pain and
inflammation, should be prepared according to stringent aseptic
methods.
This preparation can be used for the relief of nausea and vomiting associated with chemotherapy, radiation, or surgery.
This form of delivery is effective because it remains longer on the diseased area compared with rinses.
This preparation can be used in patients who have difficulty swallowing pills or in those for whom other administration routes are not desirable.
Psoriasis and other chronic skin conditions responsive to the primary ingredient may be treated with this preparation.
In unrelated cases that received widespread attention a few years ago, two college-aged women died after applying a pharmacy-compounded combination of lidocaine and tetracaine topical gel.